BVS

Bioventus Stock Analysis

AI Rating

Good
  • Quality7/10
  • Growth 9/10
  • Momentum 6/10
Bioventus sales and earnings growth
BVS Growth
Great
  • Revenue Y/Y 1.58%
  • EPS Y/Y 118.46%
  • FCF Y/Y 84.09%
Bioventus gross and profit margin trends
BVS Profitability
Neutral
  • Gross margin 67.80%
  • EPS margin 1.40%
  • ROIC 9.40%
Bioventus net debt vs free cash flow
BVS Risk
Good
  • Debt / Equity 1.6
  • Debt / FCF 5.2
  • Interest coverage 1.3

Bioventus stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Medical Devices stocks ↗